Status:
TERMINATED
Caffeine Reduction and Overactive Bladder Symptoms
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
Pfizer
Conditions:
Overactive Bladder
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
A. Statement of Objective: To conduct a randomized trial to evaluate the impact of caffeine restriction on Overactive Bladder(OAB) symptoms including urinary frequency, nocturia, incontinence episodes...
Detailed Description
Objective: To evaluate the impact of caffeine reduction education on urinary frequency. Methods: Women with overactive bladder (OAB) symptoms who scored a 6 on the Questionnaire for Urinary Incontine...
Eligibility Criteria
Inclusion
- only women 18 years and older with Overactive Bladder syndrome and who report that they consume an average of two cups of caffeinated beverages (approximately 200mg caffeine) daily will be included.
Exclusion
- Women presenting with stress predominate bladder symptoms as evaluated by the QUID, urinary tract infection or hematuria as evaluated on urine dip analysis, currently pregnant or pregnant within the past six months or history of radiation to the pelvic floor will be excluded from participation
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2009
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00754260
Start Date
March 1 2008
End Date
June 30 2009
Last Update
January 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Kammerer- Doak
Albuquerque, New Mexico, United States, 87111
2
Tola Omotosho , MD
Albuquerque, New Mexico, United States, 87131